Positron emission tomography (PET) is a noninvasive imaging technique that can be used to observe drug actions on human brain in vivo. We used 150-water PET scanning in six volunteers to examine the effects on regional cerebral activity as reflected by regional cerebral blood flow (rCBF) of a small intravenous bolus of fentanyl. rCBF was compared between scans obtained after fentanyl or a placebo using three separate statistical criteria including a pixel-by-pixel t statistic; significance was stringently defined at P values < 0.01. Anatomic locations of regional cerebral activity changes were verified by aligning rCBF PET scans with cranial magnetic resonance images using mathematical coregistration. Fentanyl administration was associated with significant increases in rCBF consistent with regional neuronal activation in both cingulate and orbitofrontal and medial prefrontal cortices, as well as caudate nuclei. These areas are responsive to nociceptive stimuli and are involved in avoidance learning, reward and addiction, visceromotor control, maintenance of attention, and pain-related affective behavior. Significant decreases were noted in both frontal and temporal areas and the cerebellum, a distribution far less extensive than that of opiate receptors in general. These data indicate that fentanyl's effects are highly localized and specifically affect cerebral regions associated with a range of pain-related behaviors.
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Accepted for publication February 7, 1996. Address correspondence and reprint requests to Leonard L. Firestone, MD, Department of Anesthesiology and Critical Care Medicine, University of Pittsburgh, A1305 Scaife Hall, Pittsburgh, PA 15261. reflected by cerebral blood flow (CBF) of a small intravenous (IV) bolus of fentanyl. Recent studies have demonstrated that pain activates specific regions of brain (6,7). In contrast, opiate receptors are widely distributed in the human brain (8) and may either depress (9) or excite (10) neuronal firing. This led us to determine whether fentanyl suppressed or activated specific brain regions both activated by pain and richest in opiate receptors.
Methods
With the approval of our review board and the Radioactive Drug Review Committee, written, informed consent was obtained from six right-handed healthy adult volunteers (four women, two men) with a mean age of 29.3 yr (range 23-36 yr). Subjects had no history of psychiatric illness or substance abuse. All female volunteers had negative serum P-human chorionic gonadotrophin test results.
PET scans were obtained under two experimental conditions: an IV bolus of fentanyll.5 pg/kg ("fentanyl") and an IV bolus of saline placebo ("control" 1996;82:1247-51 opioid effects, and subjects were blinded to the contents of syringes. Absolute silence was maintained immediately before and during scanning, and subjects were instructed to stay motionless and to fix their gaze on crosshairs projected on a computer screen. Fortyfive seconds after the bolus injection, 50 mCi of the radiotracer 150-water was administered in the right arm. An additional 15-s period elapsed before PET scanning was begun. Scan data were then acquired for a 60-s period, with a 12-min interval between all scans. The 2-min interval chosen between the fentanyl bolus and completion of data acquisition was based on the pharmacokinetics of fentanyl's effects (11, 12) . A Siemens 951R/31 scanner (Siemens Medical Systems, Hoffman
Estates, IL) was used to collect 31 parallel slices over an axial field of 10.8 cm. The inherent detector resolution was approximately 6-mm full-width at half-maximum, in both axial and transaxial directions. Positioning was optimized for obtaining brain images between the canthomeatal line and cranial vertex. Duplicate scans were obtained for each condition. After statistical analysis (below), areas of significant change in rCBF were localized and taken to reflect perturbations in regional synaptic activity (3). Individual PET scans were reconstructed using corrections for tissue attenuation determined by a prior "transmission" scan and aligned to correct for small head movements (13). Resulting data were then analyzed by statistical parametric mapping as previously reported (14, 15) . Briefly, each rCBF image was reoriented to the anterior commissural-posterior commissural (AC-PC) line, resealed to fit the standard stereotactic atlas of Talairach and Tournoux (16) , and smoothed with a three-dimensional gaussian filter. Differences in global CBF between subjects and conditions were normalized by analysis of covariance. Then, rCBF was compared between the control and fentanyl conditions using a pixel-by-pixel t statistic. For any given comparison, regions were considered significant where pixels reached P values of ~0.01, the ratio of observed/ expected number of pixels also achieved P values of co.01 by 2 analysis, and the regions extended over more than one transverse plane. Use of three separate criteria protected against Type 1 error, as demonstrated separately by the lack of significant rCBF differences in same-state (e.g., fentanyl versus fentanyl) comparisons.
Finally, regional results were converted to z scores; displayed on coronal, transverse, and sagittal views of the brain; and localized with reference to Talairach and Tournoux coordinates (16).
To verify loci of all cerebral activity changes, rCBF scans were aligned with cranial magnetic resonance (MR) images obtained using a 1.5-Tesla G.E. Signa system. PET images were then mathematically coregistered to the Tl-weighted MR images from each subject (17). Specifically, one subject's MR imaging data set was selected as a reference MR image for the group and was resliced and reoriented to the AC-PC line using Ecat software (Siemens/ CT1 PET Systems). The other subjects' MR data sets were then mathematically coregistered to this reference image, using a 12-parameter linear affine transformation developed by Woods et al. (18) . Finally, individual PET images were reregistered into the reference MR coordinate system with matrix transformation of parameters for intrasubject PET-to-MR registration and intersubject MRto-MR transformation.
All PET images were normalized to an arbitrary global value and smoothed by a three-dimensional gaussian filter, similar to the method used for statistical parametric mapping (above). Effect-size maps were then obtained by creating pixel-by-pixel maps of the mean difference in rCBF between the control and fentanyl conditions (control -fentanyl) divided by the standard deviation of the mean changes. Finally, PET (functional) data were superimposed on the MR (anatomic) images, and a color scale was used to indicate the degree of activation differences between conditions. z scores and P values corresponding to colors were calculated to facilitate comparisons with statistical parametric mapping.
Results
Comparison of rCBF during the fentanyl condition with rCBF during the control condition revealed significant (P < 0.01) increases consistent with regional neuronal activation in both cortical and subcortical areas and in both hemispheres (Fig. 1 , Table 1 ). These areas included bilateral cingulates, prefrontal cortices, and caudate nuclei. No statistically significant fentanylrelated activation was detected in the somatosensory cortical areas.
The reciprocal subtraction, that is, subtraction of the averaged images of the fentanyl condition from those of the control condition, demonstrated a few discrete areas with significant (P < 0.01) rCBF decreases in both frontal and temporal areas and the cerebellum ( Coordinates in standard stereotactic space (16) are given (in milhliters) for the maximally signifmnt pwel in each area. x = Lateral displacement from the midlme (negative for the left hemisphere); y = anteroposterior dlsplacement relative to the anterior comxmssure (negative for posterior positions); and z = vertxal position relative to the anterior commissural-posterior commissural line (negative below this line). The z score is a measure of slgniflcance; only areas with a z score >2.5 (correspondmg to a P < 0.01) are listed.
gyri (area 18; vertical extent, relative to AC-PC line: +4 to -8 mm) (Fig. 2B ).
Discussion
Recent human functional imaging studies have shown that phasic noxious thermal stimuli reliably evoke activation in the contralateral thalamus, the anterior cingulate, and the first and second somatosensory areas (SSl and SS2) (6,7). Pain-induced activation in the SSl and SS2 confirms earlier findings in electrophysiologic (19) and regional ablation experiments (20) that demonstrated the importance of these regions in interpreting sensory-discriminative aspects of pain. Anterior cingulate responses to pain have also been noted in previous electrophysiologic (21) and regional ablation (22) studies, indicating that affective/motivational aspects of nociceptive processing reside in this area. One prior case study of a single patient with chronic cancer pain (4) reported that rCBF increased bilaterally in the anterior cingulate and prefrontal cortices and in caudate and putamen in response to IV morphine. However, due to the chronic nature of the pain, brain effects of morphine in the absence of pain (the object of our study) could not be reported. Prior laboratory studies suggested that opiates might either suppress or activate neuronal activity (9,lO); the present human study indicates that focal activation responses are more pronounced. For example, a few relatively small areas of significant suppression were found to be associated with IV administration of fentanyl (Table 2) , although numerous areas with subsignificant suppression were identified in the posterior brain (Fig. 2) . In contrast, fentanyl significantly activated sizable portions of the anterior cingulate and the orbitofrontal and medial prefrontal cortices bilaterally. Anterior cingulate activation is also a prominent feature of pain-induced responses, but activation in the frontal cortical area is not. Postmortem autoradiologic studies in humans have demonstrated relatively high opiate receptor concentrations in all the brain regions we found to be activated by fentanyl, but also in many others (8). Thus, our results with fentanyl cannot be a simple consequence of some stimulating action at all opiate receptor-containing neurons.
Both pain (6,7) and fentanyl (this study) independently activate the anterior cingulate cortex, although not in identical subregions. Recent PET studies have localized pain-evoked anterior cingulate (area 24) responses in vertical planes 34-42 mm above the AC-PC line (6,23,24), whereas fentanyl activated the anterior cingulate in planes 4 mm below to 28 mm above the AC-PC line (see Table 1 ). Other studies have also identified nociceptive neurons in area 24 (21). Stimulation (25) and lesioning (26) studies also implicate area 24, as well as the infralimbic cortex (area 25) in visceromotor control. Activation of such subregions could account for anterior cingulate's contribution to pain-related affective behavior. In addition, both areas 24 and 25 project to the periaqueductal gray (27), which could provide a pathway for descending pain modulation (28) or vocalizations induced by noxious stimuli (29). The anterior cingulate cortex is also involved in avoidance learning (30), manifesting its The z vmrc 15 a measure of slgmhcance, only areas wth a z score >2 5 (correspondmg to a P < 0 01) are hsted greatest activity in the early phase of training when affective responses to noxious stimuli are greatest (31). The orbitofrontal cortex and area 25 were both activated by fentanyl in this study. Experiments using intracranial self-stimulation (32) and drug selfadministration (33) have implicated these same areas in the processes of "reward" and addiction. Further imaging studies with other narcotic agonists and antagonists may help define the link between these areas of the limbic system and narcotic addiction. The dorsomedial prefrontal cortices are known to help maintain attention (34) and may thus be linked to the obtunding effects of opioid compounds.
It is unlikely that these findings were a consequence of a direct effect of fentanyl on cerebral vasculature and were not mediated by neural activity changes. Such an explanation would require the existence of cerebral vascular opioid receptors, with the same distribution as the highly regional changes observed in CBF. To our knowledge, opiate receptors in the brain are overwhelmingly localized to neurons. Thus, it follows that the rCBF changes observed are mediated through changes in neuronal activity as a result of agonist actions at opiate receptors and, furthermore, that these changes are more focal than predicted by the widespread distribution of opiate receptors. Finally, it is also important to note that global changes in CBF from fentanyl administration, either from primary cardiovascular changes or subtle Pace, effects, are very unlikely given the small dose involved. In any case, global changes are specifically normalized during our data analysis routines and thus cannot be responsible for the regional findings.
Other possible limitations to interpretation include the fact that fentanyl is associated with physiologic effects other than analgesia and that the cerebral responses reported here may actually be a reflection of these. Furthermore, the time course of data acquisition may have captured but a 60-second average of the full array of cerebral responses to fentanyl, and the single (small) dose used may not produce responses typical of other, larger doses. Further studies with subanalgesic and larger analgesic doses of fentanyl will be needed to test the specificity of our results.
With these caveats, our results indicate that fentanyl's effects are highly localized and specifically affect cerebral regions associated with descending pain modulation, as well as vocalization and visceromotor responses to pain. The presence of attentional, learning, and reward networks in fentanyl-activated areas suggests other means by which opioids may modulate pain behavior. 
